These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2410337)

  • 1. [NK and K cell activity in children with leukemias and aplastic anemias before and after allogeneic bone marrow transplantation].
    Thränhardt H; Prager J; Fuchs D; Zintl F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(2):285-92. PubMed ID: 2410337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Human nonspecific killer cells].
    Thränhardt H; Zintl F; Milleck J; Jantscheff P; Hermann J; Fuchs D; Voigt P; Metz O; Löbe LP; Mohr F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):390-407. PubMed ID: 6182059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anemia before and after marrow transplantation.
    Livnat S; Seigneuret M; Storb R; Prentice RL
    J Immunol; 1980 Jan; 124(1):481-90. PubMed ID: 6765970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone marrow transplantation in children. II. Immunologic aspects].
    Muranaka S; Kato S; Arimori S; Nose Y; Yamamura M
    Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1176-86. PubMed ID: 3907243
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenotypic and functional characterization of peripheral blood and bone marrow natural killer cells prior to autologous transplantation.
    Arbour S; Toupin S; Bélanger R; Gyger M; Hallé JP; Perreault C; Roy DC
    Bone Marrow Transplant; 1996 Mar; 17(3):315-22. PubMed ID: 8704680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of GVHD on the recovery of NK cell activity and LAK precursors following BMT.
    Keever CA; Klein J; Leong N; Copelan EA; Avalos BR; Kapoor N; Cunningham I; Tutschka PJ
    Bone Marrow Transplant; 1993 Sep; 12(3):289-95. PubMed ID: 8241989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell activity against a thymoma cell line Thy 121 in bone marrow transplant recipients.
    Heidemann E; Schmidt H; Schüch K; Ostendorf P; Waller HD
    Klin Wochenschr; 1986 Feb; 64(3):125-30. PubMed ID: 3512902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia.
    Lowdell MW; Ray N; Craston R; Corbett T; Deane M; Prentice HG
    Bone Marrow Transplant; 1997 May; 19(9):891-7. PubMed ID: 9156262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibody-dependent cellular cytotoxicity (AAZZ) against leukemia cells--K-cell activity of human leukocytes].
    Thränhardt H; Zintl F; Plenert W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(6):824-40. PubMed ID: 6162750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
    Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
    Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone marrow transplantation in leukemia and aplastic anemia: experience with 40 patients].
    Volin L; Rajantie J; Perkkiö M; Elonen E; Saarinen U; Remes K; Hovi L; Ruutu P; Ruutu T; Siimes MA
    Duodecim; 1984; 100(20):1305-12. PubMed ID: 6391895
    [No Abstract]   [Full Text] [Related]  

  • 14. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.
    Lotzová E; Savary CA; Herberman RB
    J Immunol; 1987 Apr; 138(8):2718-27. PubMed ID: 3494084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantation: analysis of the surface expression and function of activating NK receptors.
    Vitale C; Chiossone L; Morreale G; Lanino E; Cottalasso F; Moretti S; Dini G; Moretta L; Mingari MC
    Mol Immunol; 2005 Feb; 42(4):405-11. PubMed ID: 15607791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells in peripheral blood after autologous bone marrow transplantation: a combined phenotypic and functional study.
    Jorgensen H; Hokland P; Jensen T; Basse P; Hokland M
    Nat Immun; 1995; 14(3):164-72. PubMed ID: 8832900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
    Koehl U; Esser R; Zimmermann S; Tonn T; Kotchetkov R; Bartling T; Sörensen J; Grüttner HP; Bader P; Seifried E; Martin H; Lang P; Passweg JR; Klingebiel T; Schwabe D
    Klin Padiatr; 2005; 217(6):345-50. PubMed ID: 16307421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of aplastic anemia in children by bone marrow transplantation (author's transl)].
    Wündisch GF
    Klin Padiatr; 1977 Jan; 189(8):50-9. PubMed ID: 320373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.